|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 471/04 | |
| C07D 498/04 | |||
| A61K 31/437 | |||
| A61P 25/24 |
| (11) | Number of the document | 1735308 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05725295.9 |
| Date of filing the European patent application | 2005-03-09 | |
| (97) | Date of publication of the European application | 2006-12-27 |
| (45) | Date of publication and mention of the grant of the patent | 2008-09-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/008049 |
| Date | 2005-03-09 |
| (87) | Number | WO 2005/087769 |
| Date | 2005-09-22 |
| (30) | Number | Date | Country code |
| 551836 P | 2004-03-09 | US |
| (72) |
CLARK, Robin, D., US
RAY, Nicholas, C., GB
BLANEY, Paul, M., GB
HURLEY, Christopher A., GB
WILLIAMS, Karen, GB
|
| (73) |
Corcept Therapeutics, Inc.,
Suite A, 275 Middlefield Road, Menlo Park, CA 94025,
US
|
| (54) | FUSED RING AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS |
| FUSED RING AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS |